D.Sole
Pittsburgh · Founded 2023
About D.Sole
At D.Sole, we are advancing the development of remote patient monitoring in podiatry with our multimodal foot insoles designed for the early detection and monitoring of diabetic foot complications, such as ulcers and deformities. Our complete foot physiological data along with advanced machine learning algorithms provides clinicians with evidence-based insights for targeted foot treatments. We are ten times more affordable than current market options and detect 15-foot complications’far outperforming competitors who detect just one. D.Sole could save wound clinics in hospitals over $100 million annually by lowering readmission rates for foot complications. Private insurers could save over $1 billion by cutting costs on amputations and wound care.
Company Facts
- Founded: 2023
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $125.0K
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: https://www.d-sole.com
- Phone: +1 848-213-1094
Industries & Categories
Health Care, Medical Device, Wearables
Social Profiles
Canonical: https://fsome.com/organization/d-sole-42914 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.